A research team led by Prof. Sun Jianwei has introduced a novel air-stable chiral phosphine-catalyzed approach for the enantioselective synthesis of antiviral candidates.
This method emphasizes a metal-free route, which could streamline the production of enantioenriched S(IV)-stereogenic compounds.
The implications of this advancement are significant for both organic synthesis and medicinal chemistry, potentially enhancing throughput and efficiency in drug development.